NCT00367471 - Combination Of Lapatinib With Carboplatin, Paclitaxel, and With or Without Trastuzumab In Metastatic Breast Cancer. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 7, 2006

Primary Completion Date

December 22, 2010

Study Completion Date

September 12, 2019

Conditions

Neoplasms, Breast

Interventions

DRUG

lapatinib

Lapatinib (GW572016) is a potent small molecule, reversible inhibitor of both EGFR and ErbB2 tyrosine kinases

DRUG

carboplatin

An alkylating agent used in the treatment of some cancers

DRUG

trastuzumab

A monoclonal antibody that interferes with the HER2/neu receptor

DRUG

paclitaxel

A mitotic inhibitor used in cancer treatment

Trial Locations (3)

Novartis Investigative Site, Greensboro

Novartis Investigative Site, Indianapolis

Novartis Investigative Site, La Jolla